Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA in Adults With Myotonic Dystrophy
NCT00167609Phase 3Completed
- Sponsor
- Université de Versailles Saint-Quentin-en-Yvelines
- Start
- Nov 2004
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in myotonic dystrophy type 1 (DM1), sponsored by Université de Versailles Saint-Quentin-en-Yvelines. Started Nov 2004; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
myotonic dystrophy type 1 (DM1)
Beyond the preview
Go deeper on NCT00167609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167609.